Portfolio

MTI specializes in innovative metabolomics-based diagnostics for the healthcare market. Their product PolypDx is the first and only urine-based test for detection of adenomatous polyps – the precursor to colorectal cancer.  

michaelmclean@tribunecapital.ca | 403-389-9832

 

CALGARY

505, Bow Valley Square 3

255-5th Avenue SW, Calgary AB T2P 2V7

WEYBURN

1150 Railway Ave, Weyburn, SK S4H 0B3     

© 2019 Tribune Capital